Global Pleural Diseases Therapeutics Market to Reach USD 9.4 Billion by 2033, Growing at a 6.5% CAGR
Global Pleural Diseases Therapeutics MarketThe global market for pleural diseases therapeutics is projected to experience ...
One of the primary factors fueling the growth of the DOACs market is the rapid uptake and expected utilization within the ...
The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...
FRANKFURT: The CEO of pharmaceuticals giant Roche, opens new tab said authorities should block the takeover of contract drug ...
AllianceQUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery 24.10.2024 / 09:30 CET/CESTThe issuer is solely responsible for the content of this ...
It’s important to maintain a temperature of 77 degrees or cooler, and above freezing, so efficacy is highest when the product ...
Zacks.com on MSN1h
CTLT Stock Falls as Potential Hindrance to NVO Buyout Deal IncreasesShares of Catalent CTLT lost 0.9% on Oct. 23 with the rise in uncertainty related to its acquisition by Novo Holding ...
The Roundup covers notable class action decisions from federal appellate courts and notable Supreme Court class action cert petitions.
As the EU patent expires on its flagship respiratory diseases product, Spiriva, Boehringer Ingelheim is looking to newer diabetes and respiratory drugs under the leadership of a new CEO.
At the forefront of poultry production, USPOULTRY's 2024 Live Production, Welfare and Biosecurity Seminar — held in Tucker, ...
The statewide public defender shortage may violate the constitutional right to legal defense, a UPenn report found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback